Waters Corporation Announces Third Quarter 2025 Financial Results and Raises Guidance

Details

GAAP diluted earnings per share (EPS) were $2.50, down from $2.71 in the same period last year, while non-GAAP EPS increased to $3.40 from $2.93, exceeding guidance. The company also raised its full-year 2025 constant currency sales growth guidance to +6.7% to +7.3% and non-GAAP EPS guidance to $13.05 to $13.15, reflecting year-over-year growth of +10% to +11%.

Items reported

About Waters Corporation

Waters Corporation is a leading entity in the field of analytical instruments and software. It primarily focuses on providing laboratory solutions for a variety of sectors, including pharmaceuticals, healthcare, food and beverage, and chemical analysis. The company's offerings include high-performance liquid chromatography, mass spectrometry systems, and various supporting technologies used for advanced research in life sciences. Waters Corporation is pivotal in enhancing laboratory productivity, offering cutting-edge research tools that assist in drug development, quality control, and environmental testing. Operating globally, it serves a wide array of clients, including academic institutions, government agencies, and private industry players. With its commitment to innovation and precision, Waters Corporation plays a crucial role in advancing scientific and technological progress in multiple critical industries worldwide.